NEW YORK (GenomeWeb) – Bio-Rad Laboratories said today that its board of directors has authorized a new share repurchase program, granting the company authority to repurchase up to $250 million of outstanding shares of its stock on a discretionary basis.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

The Economist writes that an increasing number of scientific journals don't do peer review.

In Science this week: genetic overlap among many psychiatric disorders, and more.